[Application of the MELD scale for the estimation of treatment efficacy in patients with hepatic cirrhosis and hepatorenal syndrome type II using extracorporeal methods of hemocorrection].
The results of treatment of 69 patients, suffering hepatic cirrhosis (HC) in decompensation stage with hepatorenal syndrome, were analyzed, in whom extracorporeal methods of hemocorrection (extracorporeal sorption with ultrafiltration of ascitic liquor and the albumin peritoneal dialysis) were applied. The patients state severity as well as the therapy efficacy were estimated in accordance with the MELD (Model of End-Stage Liver Disease) scale. High informativity of the abovementioned estimation system was established, concerning prognosis for their life duration in the patients, suffering HC.
V I
VI
Rusyn
Ie S
IeS
Sirchak
Kh V
KhV
Fut'ko
V V
VV
Avdieiev
D005260:Female; D017583:Hemodiafiltration / Q000379:methods*; D006530:Hepatorenal Syndrome / Q000097:blood* / Q000150:complications / Q000628:therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood* / Q000150:complications / Q000628:therapy; D008297:Male; D010530:Peritoneal Dialysis / Q000379:methods*; D011379:Prognosis; D012720:Severity of Illness Index; D016019:Survival Analysis; D016896:Treatment Outcome